OK Science and Technology's declining ROCE and sales, along with increased capital employment, are worrisome. Long-term shareholders have seen a 48% investment depreciation over the past year.

Despite the low ROE, the company's earnings growth is considered decent due to its efficient management and low payout ratio. The company's future earnings growth is expected to continue expanding according to the latest analyst forecasts.